IXC | Small Caps

Invex Therapeutics ASX IXC biotech Dr Megan Baldwin

Invex Therapeutics appoints biotech expert Dr Megan Baldwin to its board

February 16, 2021

Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has welcomed seasoned drug development expert Dr Megan Baldwin to the board as an independent non-executive director, effective t...

Invex Therapeutics ASX IXC idiopathic intracranial hypertension IIH phase 3 drug

Invex Therapeutics pushes on with phase three trial design to repurpose drug for brain disorder

January 27, 2021

Invex Therapeutics (ASX: IXC) is aiming to hit some significant milestones in 2021 in its bid to use a diabetic drug for a neurological condition in desperate need for treatment. The biopharmaceuti...

Invex Therapeutics ASX IXC Idiopathic Intracranial Hypertension headache

Invex Therapeutics raises $26 million as it plans for Phase 3 clinical trial

May 22, 2020

Two days since publishing its Phase 2 clinical trial results and announcing “clear evidence” that its Exeatide drug is effective at reducing intracranial pressure in Idiopathic Intracranial Hypertensi...

Invex Therapeutics ASX IXC repurpose diabetic drug brain disorders Exenatide IPO

Invex Therapeutics aims to repurpose a diabetic drug for brain disorders

July 3, 2019

Biopharmaceutical company Invex Therapeutics is planning to make its ASX debut this week under the ticker code “IXC” with ambitions to repurpose an approved diabetes drug for some neurological conditi...

RECENT POSTS

EMVision ASX EMV Medical Devices stroke patients 2020 2021

EMVision Medical Devices to expand clinical studies of portable brain scanner on stroke patients

February 25, 2021

Blackstone Minerals ASX BSX Taipan new nickel sulphide discovery Ta Cuong prospect Ta Khoa project

Blackstone Minerals makes new nickel sulphide discovery at Ta Cuong prospect

February 25, 2021

Duke Exploration DEX ASX Bundarra Waitara Copper silver porphyry

Duke Exploration expands Queensland copper potential with grant of Waitara tenement

February 25, 2021

RooLife Group ASX RLG Chinese online market half-yearly results revenue

RooLife Group’s beds-in strategy to stay connected to primary Chinese online market

February 25, 2021

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

SPACs Australian cash boxes listing stock exchange SPAC

SPACs: Australian cash boxes were way ahead of their time

February 25, 2021

Bitcoin ASX crypto exchange traded funds blockchain technology

How to play the listed Bitcoin game

February 24, 2021

ME Bank of Queensland ASX BOQ big four Australia

Big four banks on notice after Bank of Queensland snaps up ME Bank for $1.3b

February 23, 2021

TRENDING POSTS

ME Bank of Queensland ASX BOQ big four Australia

Big four banks on notice after Bank of Queensland snaps up ME Bank for $1.3b

Lefroy Exploration ASX LEX Burns gold copper mineralisation drilling

Lefroy Exploration unearths high-grade gold and copper southeast of Kalgoorlie

Copper investors stocks ASX 2021 forecast

Goldman Sachs raises 12 month copper price target to US$10,500/t

Bitcoin ASX crypto exchange traded funds blockchain technology

How to play the listed Bitcoin game

Fatfish Group subsidiary Abelco record profit ASX FFG 2020

Fatfish Group subsidiary Abelco posts record full-year profit

Latin Resources ASX LRS halloysite Noombenberry kaolin Western Australia

Latin Resources confirms ‘very’ high-grade halloysite at Noombenberry along with kaolin

Airtasker IPO ASX

Airtasker IPO to bring gig economy to the ASX

Carawine Resources ASX CWX gold discovery Western Australia Tropicana North

Carawine Resources reveals ‘exciting’ gold discovery at Hercules in WA

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.